Skip to Content

'
Howard Colman, M.D., Ph.D.

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1997 Washington University School of Medicine, St. Louis, MO, MD, Medicine
1997 Washington University School of Medicine, St. Louis, MO, PHD, Neuroscience
1989 Brown University, Providence, RI, BS, with Honors, Neural Sciences

Selected Publications

Peer-Reviewed Original Research Articles
1. Colman H, Zhang L, Sulman E, McDonald M, Latif Shooshtari N, Rivera A, Popoff S, Nutt C, Louis D, Cairncross G, Gilbert M, Phillips H, Mehta M, Chakravarti A, Pelloski C, Bhat KR, Feuerstein B, Jenkins R, Aldape K. A multigene predictor of outcome in glioblastoma. Neuro-Onc. In Press.
2. Freire P, Vilela M, Deus H, Kim YW, Koul D, Colman H, Aldape KD, Bogler O, Yung WK Coombes K, Mills GB, Vasconcelos AT, Almeida JS. Exploratory analysis of the copy number alterations in glioblastoma multiforme. PLoS One 3((12)):e4076, 12/2008. PMID: 19115005.
3. Colman H, Aldape KD. Molecular Predictors in Glioblastoma- Towards Personalized Therapy. Archives of Neurology. Arch Neurol 65(7):877-83, 7/2008. PMID: 18625854.
4. Jiang H, Gomez-Manzano C, Aoki H, Alonso MM, Kondo S, McCormick F, Xu J, Kondo Y, Bekele BN, Colman H, Lang FF, Fueyo J. Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death. J Natl Cancer Inst 99(18):1410-4, 9/2007. PMID: 17848677.
5. Pelloski CE, Ballman KV, Furth AF, Zhang L, Lin E, Sulman EP, Bhat K, McDonald JM, Yung WK, Colman H, Woo SY, Heimberger AB, Suki D, Prados MD, Chang SM, Barker FG, Buckner JC, James CD, Aldape K. Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma. J Clin Oncol 25(16)(16):2288-94, 6/2007. PMID: 17538175.
6. Colman H, Berkey B, Maor M, Groves MD, Schultz C, Vermeulin S, Nelson D, Mehta M, Yung WKA. Phase II Radiation Therapy Oncology Group Trial of Conventional Radiation Therapy Gollowed by Treatment with Recombinant Interferon-B for supratentorial glioblastoma - Results of RTOG 9710. Int J Radiat Oncol Biol Phys 66(3):818-24, 11/2006.
7. Pelloski CE, Lin E, Zhang L, Yung WK, Colman H, Liu JL, Woo SY, Heimberger AB, Suki D, Prados M, Chang S, Barker FG, 3rd, Fuller GN, Aldape KD. Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. Clin Cancer Res 12:3935-41, 7/2006. PMID: 16818690.
8. Colman H, Giannini C, Huang L, Gonzalez J, Hess K, Bruner J, Fuller G, Langford L, Pelloski C, Aaron J, Burger P, Aldape K. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas. Am J Surg Pathol 30:657-64, 5/2006. PMID: 16699322.
9. Phillips HS, Kharbanda S, Chen R, Forrest W, Soriano R, Wu TD, Misra A, Nigro J, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein F, Aldape KD. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9:157-173, 3/2006.

Invited Articles
1. Sulman E, Aldape K,Colman H. Brain Tumor Stem Cells. Curr Probl Cancer 32(3):125-42, 5/2008. PMID: 18501775.

Last updated: 8/31/2009